StockProfiler.US: Small Cap Stock Market Picks for Monday: AXXE & POSC

MARKHAM, ON, Aug 26, 2010 -- Axxess Pharma Inc. (PINKSHEETS: AXXE), a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription medical products, is pleased to announce they anticipate generating an additional $700,000 in annual sales from their pre-natal, non-constipating multi-vitamin Triferrex PN.

Axxess Pharma Inc. closed at $0.021 Friday, trading 74,500 shares.

Axxess Pharma Inc. Anticipates Additional $700,000 in Annual Sales From Pre-Natal, Non-Constipating Multi-Vitamin Triferrex PN

About Axxess Pharma Inc.

Axxess Pharma Inc. is a specialty pharmaceutical company that focuses on the marketing of dermatological, therapeutic nutritionals, pain management and diagnostic products in Canada and abroad since 1997. Axxess owns 22 established pharmaceutical prescription products that have proven sales in Canada and internationally. The company has an experienced management team and field sales force to market products nationally to hospitals and retail pharmacies as well as specialized practice areas including Dermatology and Nephrology, Neurology and Urology.

Free AXXE small cap stock news and charts available at http://www.stockprofiler.us/Company/AXXE

For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

INDIANAPOLIS, Aug 30, 2010 -- Positron Corporation (OTCBB: POSC) is pleased to announce K. Lance Gould M.D. as the keynote speaker for their upcoming cardiac PET symposium, held at the American Society of Nuclear Cardiology (ASNC) annual meeting, September 23-26 in Philadelphia, PA.

Positron Corporation closed at $0.061 Friday, trading 2,204,640 shares.

Positron to Host Cardiac PET Symposium at American Society of Nuclear Cardiology Annual Meeting; Renowned Cardiac Expert Dr. K. Lance Gould to be Keynote Speaker

About Positron

Positron is a molecular imaging company focused on Nuclear Cardiology. Positron utilizes its proprietary product line to provide unique solutions to the Nuclear Medicine community ranging from imaging to radiopharmaceutical distribution. Positron products include: the Attrius(TM), a PET imaging device; the Pulse(R), a SPECT imaging device; the Nuclear Pharm-Assist(R), an automated radiopharmaceutical distribution device; and the Tech-Assist(TM), a radiopharmaceutical injection shield. More information about Positron is available at positron.com.

For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

StockProfiler.US Announcement!

Membership with access to enhanced stock investing tools is now FREE! Claim yours at http://www.stockprofiler.us/Register

Stay connected with StockProfiler.US – Fan up with us on Facebook (keyword: StockProfiler.US) or follow us on Twitter at http://twitter.com/StockProfilerUS

View free small cap company videos and product reviews at our YouTube channel. Visit http://www.youtube.com/StockProfilerUS

-------------------------------------------

About StockProfiler.US:

StockProfiler.US is a media source for publicly traded small cap companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.

Call us at (603) 424-4420 or email info@stockprofiler.us

-------------------------------------------

Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.

This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Stock Profiler.US, LLC's News Division includes but is not limited to: http://www.stockprofiler.us, http://www.associatesfortune.com,
http://www.fastmoneytalk.com, http://www.markettelegraph.com,http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.

Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

To view full disclaimers and terms of use, go to http://www.stockprofiler.us/Disclaimer

-------------------------------------------

Keywords: axxe, axxe stock, axxe stock news, axxe stock alerts, axxe company news, axxe small cap stock, small cap news, small cap stock alerts, small cap stock updates, small cap stock news updates, small cap stock profile

StockProfiler.US: Hot Pharmaceutical Penny Stocks: AXXE & SOHM

MARKHAM, ON, Aug 26, 2010 -- Axxess Pharma Inc. (PINKSHEETS: AXXE), a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription medical products, is pleased to announce they anticipate generating an additional $700,000 in annual sales from their pre-natal, non-constipating multi-vitamin Triferrex PN.

Axxess Pharma Inc. closed at $0.024 Thursday, trading 65,800 shares.

Axxess Pharma Inc. Anticipates Additional $700,000 in Annual Sales From Pre-Natal, Non-Constipating Multi-Vitamin Triferrex PN

About Axxess Pharma Inc.

Axxess Pharma Inc. is a specialty pharmaceutical company that focuses on the marketing of dermatological, therapeutic nutritionals, pain management and diagnostic products in Canada and abroad since 1997. Axxess owns 22 established pharmaceutical prescription products that have proven sales in Canada and internationally. The company has an experienced management team and field sales force to market products nationally to hospitals and retail pharmacies as well as specialized practice areas including Dermatology and Nephrology, Neurology and Urology.

Free AXXE penny stock news and charts available at http://www.stockprofiler.us/Company/AXXE

For additional penny stock news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

BUENA PARK, CA, August 27, 2010 -- SOHM, Inc. (PINKSHEETS: SHMN) announced today that it has further broadened its international sales channels in Southeast Asia by signing an exclusive distribution agreement for the marketing and distribution of SOHM's private label generic pharmaceutical products in Sri Lanka.

SOHM, Inc. closed at $0.0610 Thursday, trading 1,895,920 shares.

SOHM Signs Exclusive Agreement for Distribution of Generic Pharmaceuticals in Sri Lanka

About SOHM, Inc.

SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters are located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. sohm.com

For additional penny stock news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

StockProfiler.US Announcement!

Membership with access to enhanced stock investing tools is now FREE! Claim yours at http://www.stockprofiler.us/Register

Stay connected with StockProfiler.US – Fan up with us on Facebook (keyword: StockProfiler.US) or follow us on Twitter at http://twitter.com/StockProfilerUS

View free penny stock company videos and product reviews at our YouTube channel. Visit http://www.youtube.com/StockProfilerUS

-------------------------------------------

About StockProfiler.US:

StockProfiler.US is a media source for publicly traded penny stock companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.

Call us at (603) 424-4420 or email info@stockprofiler.us

-------------------------------------------

Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.

This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Stock Profiler.US, LLC's News Division includes but is not limited to: http://www.stockprofiler.us, http://www.associatesfortune.com,
http://www.fastmoneytalk.com, http://www.markettelegraph.com,http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.

Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

To view full disclaimers and terms of use, go to http://www.stockprofiler.us/Disclaimer

-------------------------------------------

Keywords: axxe, axxe stock, axxe stock news, axxe stock alerts, axxe company news, axxe penny stock, penny stock news, penny stock alerts, penny stock updates, penny stock news updates, penny stock profile

MARKHAM, ON, Aug 26, 2010 -- Axxess Pharma Inc. (PINKSHEETS: AXXE), a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription medical products, is pleased to announce they anticipate generating an additional $700,000 in annual sales from their pre-natal, non-constipating multi-vitamin Triferrex PN.

Axxess Pharma Inc. closed at $0.029 Wednesday, trading 795,653 shares.

Axxess Pharma Inc. Anticipates Additional $700,000 in Annual Sales From Pre-Natal, Non-Constipating Multi-Vitamin Triferrex PN

About Axxess Pharma Inc.

Axxess Pharma Inc. is a specialty pharmaceutical company that focuses on the marketing of dermatological, therapeutic nutritionals, pain management and diagnostic products in Canada and abroad since 1997. Axxess owns 22 established pharmaceutical prescription products that have proven sales in Canada and internationally. The company has an experienced management team and field sales force to market products nationally to hospitals and retail pharmacies as well as specialized practice areas including Dermatology and Nephrology, Neurology and Urology.

Free AXXE small cap stock news and charts available at http://www.stockprofiler.us/Company/AXXE

For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

BUENA PARK, CA, August 26, 2010 -- SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, today announced that it has posted a 1,000 percent year-over-year increase in revenue for the second quarter ending June 30, 2010.

SOHM, Inc. closed at $0.0577 Wednesday, trading 794,490 shares.

SOHM Reports Consecutive Record Quarters With 1,000 Percent Year-Over-Year Revenue Increase for the Second Quarter 2010

About SOHM, Inc.

SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters are located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. sohm.com

For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

StockProfiler.US Announcement!

Membership with access to enhanced stock investing tools is now FREE! Claim yours at http://www.stockprofiler.us/Register

Stay connected with StockProfiler.US – Fan up with us on Facebook (keyword: StockProfiler.US) or follow us on Twitter at http://twitter.com/StockProfilerUS

View free small cap company videos and product reviews at our YouTube channel. Visit http://www.youtube.com/StockProfilerUS

-------------------------------------------

About StockProfiler.US:

StockProfiler.US is a media source for publicly traded small cap companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.

Call us at (603) 424-4420 or email info@stockprofiler.us

-------------------------------------------

Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.

This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Stock Profiler.US, LLC's News Division includes but is not limited to: http://www.stockprofiler.us, http://www.associatesfortune.com,
http://www.fastmoneytalk.com, http://www.markettelegraph.com,http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.

Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

To view full disclaimers and terms of use, go to http://www.stockprofiler.us/Disclaimer

-------------------------------------------

Keywords: axxe, axxe stock, axxe stock news, axxe stock alerts, axxe company news, axxe small cap stock, small cap news, small cap stock alerts, small cap stock updates, small cap stock news updates, small cap stock profile

StockProfiler.US: Small Cap Pharmaceutical Companies AXXE & APHY

MARKHAM, ON, August 18, 2010 -- Axxess Pharma, Inc. (PINKSHEETS: AXXE), a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription drugs, wishes to advise shareholders and other interested parties that Senior Management has become aware of an unauthorized press release being disseminated to the public by Mina Mar Marketing Group.

Axxess Pharma, Inc. closed at $0.015 Thursday, trading 24,300 shares.

Axxess Pharma, Inc. Reports Unauthorized and Inaccurate Press Release Distributed by Mina Mar Marketing Group

About Axxess Pharma, Inc.

Axxess Pharma, Inc. is a specialty pharmaceutical company that focuses on the marketing of dermatological, therapeutic nutritionals, pain management and diagnostic products in Canada and abroad since 1997. Axxess owns 22 established pharmaceutical prescription products that have proven sales in Canada and internationally. The company has an experienced management team and field sales force to market products nationally to hospitals and retail pharmacies as well as specialized practice areas including Dermatology and Nephrology, Neurology and Urology.

Free AXXE small cap stock news and charts available at http://www.stockprofiler.us/Company/AXXE

For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

FRISCO, Texas, Aug. 19, 2010 -- Assured Pharmacy (PINKSHEETS: APHY), a leading specialty pharmacy providing prescription medications to more than 3,000 sufferers of chronic pain announced that total sales on a same store basis for the month of July 2010 were $1,422,163 which equates to $67,722 per business day.

Assured Pharmacy closed at $0.009 Thursday, trading 708,000 shares.

Assured Pharmacy Reports Same Store Sales for the Month of July 2010

About Assured Pharmacy, Inc.

Assured Pharmacy, Inc. is engaged in the business of operating specialty pharmacies that primarily dispense highly regulated pain medication. The Company derives its revenue primarily from the sale of prescription drugs and does not keep in inventory non-prescription drugs or health and beauty related products inventoried at traditional pharmacies. The Company offers physicians the ability to electronically transmit prescriptions to its pharmacies. The majority of the Company's business is derived from repeat business from its customers. "Walk-in" prescriptions from physicians are limited. The Company currently has four operating pharmacies. Three of those pharmacies are wholly owned and the Company has a 94.8% ownership interest in the other pharmacy.

For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

StockProfiler.US Announcement!

Membership with access to enhanced stock investing tools is now FREE! Claim yours at http://www.stockprofiler.us/Register

Stay connected with StockProfiler.US – Fan up with us on Facebook (keyword: StockProfiler.US) or follow us on Twitter at http://twitter.com/StockProfilerUS

View free small cap company videos and product reviews at our YouTube channel. Visit http://www.youtube.com/StockProfilerUS

-------------------------------------------

About StockProfiler.US:

StockProfiler.US is a media source for publicly traded small cap companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.

Call us at (603) 424-4420 or email info@stockprofiler.us

-------------------------------------------

Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.

This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Stock Profiler.US, LLC's News Division includes but is not limited to: http://www.stockprofiler.us, http://www.associatesfortune.com,
http://www.fastmoneytalk.com, http://www.markettelegraph.com,http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.

Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

To view full disclaimers and terms of use, go to http://www.stockprofiler.us/Disclaimer

-------------------------------------------

Keywords: axxe, axxe stock, axxe stock news, axxe stock alerts, axxe company news, axxe small cap stock, small cap news, small cap stock alerts, small cap stock updates, small cap stock news updates, small cap stock profile

StockProfiler.US: Pharmaceutical Penny Stock News Alerts: Axxess Pharma, Inc. & Nutra Pharma Corporation

MARKHAM, ON, August 18, 2010 -- Axxess Pharma, Inc. (PINKSHEETS: AXXE), a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription drugs, wishes to advise shareholders and other interested parties that Senior Management has become aware of an unauthorized press release being disseminated to the public by Mina Mar Marketing Group.

Axxess Pharma, Inc. closed at $0.024 Wednesday, trading 332,828 shares.

Axxess Pharma, Inc. Reports Unauthorized and Inaccurate Press Release Distributed by Mina Mar Marketing Group

About Axxess Pharma, Inc.

Axxess Pharma, Inc. is a specialty pharmaceutical company that focuses on the marketing of dermatological, therapeutic nutritionals, pain management and diagnostic products in Canada and abroad since 1997. Axxess owns 22 established pharmaceutical prescription products that have proven sales in Canada and internationally. The company has an experienced management team and field sales force to market products nationally to hospitals and retail pharmacies as well as specialized practice areas including Dermatology and Nephrology, Neurology and Urology.

Free AXXE penny stock news and charts available at http://www.stockprofiler.us/Company/AXXE

For additional penny stock news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

CORAL SPRINGS, FL, August 19, 2010 -- Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), Human Immunodeficiency Virus (HIV), Multiple Sclerosis (MS) and Pain, announced today that it has begun the drug registration process in India for its Nyloxin line of pain relievers.

Nutra Pharma Corporation closed at $0.16 Wednesday, trading 246,915 shares.

Nutra Pharma Begins Drug Registration Process in India for Nyloxin -- A Treatment for Moderate to Severe Chronic Pain

About Nutra Pharma Corp.

Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Adrenomyeloneuropathy (AMN), Multiple Sclerosis (MS), and Human Immunodeficiency Virus (HIV). Additionally, the Company markets several drug products for sale for the treatment of pain under the brands Cobroxin and Nyloxin. For additional information about Nutra Pharma, visit: NutraPharma.com

For additional penny stock news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

StockProfiler.US Announcement!

Membership with access to enhanced stock investing tools is now FREE! Claim yours at http://www.stockprofiler.us/Register

Stay connected with StockProfiler.US – Fan up with us on Facebook (keyword: StockProfiler.US) or follow us on Twitter at http://twitter.com/StockProfilerUS

View free penny stock company videos and product reviews at our YouTube channel. Visit http://www.youtube.com/StockProfilerUS

-------------------------------------------

About StockProfiler.US:

StockProfiler.US is a media source for publicly traded penny stock companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.

Call us at (603) 424-4420 or email info@stockprofiler.us

-------------------------------------------

Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.

This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Stock Profiler.US, LLC's News Division includes but is not limited to: http://www.stockprofiler.us, http://www.associatesfortune.com,
http://www.fastmoneytalk.com, http://www.markettelegraph.com,http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.

Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

To view full disclaimers and terms of use, go to http://www.stockprofiler.us/Disclaimer

-------------------------------------------

Keywords: axxe, axxe stock, axxe stock news, axxe stock alerts, axxe company news, axxe penny stock, penny stock news, penny stock alerts, penny stock updates, penny stock news updates, penny stock profile

StockProfiler.US: Wednesday's Penny Stock Updates: Axxess Pharma, Inc. & Hall of Fame Beverages, Inc.

MARKHAM, ON, August 18, 2010 -- Axxess Pharma, Inc. (PINKSHEETS: AXXE), a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription drugs, wishes to advise shareholders and other interested parties that Senior Management has become aware of an unauthorized press release being disseminated to the public by Mina Mar Marketing Group.

Axxess Pharma, Inc. closed at $0.028 Tuesday, trading 150,000 shares.

Axxess Pharma, Inc. Reports Unauthorized and Inaccurate Press Release Distributed by Mina Mar Marketing Group

About Axxess Pharma, Inc.

Axxess Pharma, Inc. is a specialty pharmaceutical company that focuses on the marketing of dermatological, therapeutic nutritionals, pain management and diagnostic products in Canada and abroad since 1997. Axxess owns 22 established pharmaceutical prescription products that have proven sales in Canada and internationally. The company has an experienced management team and field sales force to market products nationally to hospitals and retail pharmacies as well as specialized practice areas including Dermatology and Nephrology, Neurology and Urology.

Free AXXE penny stock news and charts available at http://www.stockprofiler.us/Company/AXXE

For additional penny stock news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

LOS ANGELES, CA, August 18, 2010 -- Hall of Fame Beverages, Inc. (PINKSHEETS: HFBG) CEO Steve Hendricks announces that the company's first production run of its brand Grand Ma Ma's Sweet Southern Tea is complete.

Hall of Fame Beverages, Inc. closed at $0.0005 Tuesday, trading 15,704,000 shares.

Hall of Fame Beverages CEO Announces the Return of Grand Ma Ma

About Hall of Fame Beverages

Hall of Fame Beverages, Inc. is a new lifestyle company dedicated to building long-term success through the creation, manufacture, distribution, and marketing of innovative non-alcoholic beverages recognized for their fresh, standout brand identities that rise above the plethora of average products. Hall of Fame Beverages is a team of visionary and seasoned beverage industry executives who intend to leverage their expertise and their established resources in beverage commerce to make Hall of Fame Beverages one of the industry's big winners via its signature brands Atomic Dogg Super Soda and Grand Ma Ma's Sweet Southern Tea.

For additional penny stock news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

StockProfiler.US Announcement!

Membership with access to enhanced stock investing tools is now FREE! Claim yours at http://www.stockprofiler.us/Register

Stay connected with StockProfiler.US – Fan up with us on Facebook (keyword: StockProfiler.US) or follow us on Twitter at http://twitter.com/StockProfilerUS

View free penny stock company videos and product reviews at our YouTube channel. Visit http://www.youtube.com/StockProfilerUS

-------------------------------------------

About StockProfiler.US:

StockProfiler.US is a media source for publicly traded penny stock companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.

Call us at (603) 424-4420 or email info@stockprofiler.us

-------------------------------------------

Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.

This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Stock Profiler.US, LLC's News Division includes but is not limited to: http://www.stockprofiler.us, http://www.associatesfortune.com,
http://www.fastmoneytalk.com, http://www.markettelegraph.com,http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.

Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

To view full disclaimers and terms of use, go to http://www.stockprofiler.us/Disclaimer

-------------------------------------------

Keywords: axxe, axxe stock, axxe stock news, axxe stock alerts, axxe company news, axxe penny stock, penny stock news, penny stock alerts, penny stock updates, penny stock news updates, penny stock profile

StockProfiler.US: Small Cap Stock News Tips: Axxess Pharma, Inc. & UV Flu Technologies, Inc.

MARKHAM, ON, Aug 16, 2010 -- Axxess Pharma, Inc. (PINKSHEETS: AXXE), a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription medical products, is pleased to report they have generated $1.3 million in annual sales from their non-constipating multi-vitamin Triferrex 150.

Axxess Pharma, Inc. closed at $0.028 Tuesday, trading 150,000 shares.

Axxess Pharma, Inc. Reports $1.3 Million in Annual Sales From Non-Constipating Multi-Vitamin Triferrex 150

About Axxess Pharma, Inc.

Axxess Pharma, Inc. is a specialty pharmaceutical company that focuses on the marketing of dermatological, therapeutic nutritionals, pain management and diagnostic products in Canada and abroad since 1997. Axxess owns 22 established pharmaceutical prescription products that have proven sales in Canada and internationally. The company has an experienced management team and field sales force to market products nationally to hospitals and retail pharmacies as well as specialized practice areas including Dermatology and Nephrology, Neurology and Urology.

Free AXXE small cap stock news and charts available at http://www.stockprofiler.us/Company/AXXE

For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

CENTERVILLE, MA, August 18, 2010 -- UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce that it has signed an agreement with Trade Network, Inc., dba Creative Media and Buying Services, to produce a series of television advertisements in order to publicize a national awareness campaign featuring the ViraTech UV-400 product line, and its proven health benefits in relationship to the ongoing and growing dangers presented by poor indoor air quality in homes, and workplaces across the nation.

UV Flu Technologies, Inc. closed at $0.375 Tuesday, trading 78,153 shares.

UV Flu Technologies Plans National Television Sales Awareness Campaign

About UV Flu Technologies, Inc.

UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device.

For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

StockProfiler.US Announcement!

Membership with access to enhanced stock investing tools is now FREE! Claim yours at http://www.stockprofiler.us/Register

Stay connected with StockProfiler.US – Fan up with us on Facebook (keyword: StockProfiler.US) or follow us on Twitter at http://twitter.com/StockProfilerUS

View free small cap company videos and product reviews at our YouTube channel. Visit http://www.youtube.com/StockProfilerUS

-------------------------------------------

About StockProfiler.US:

StockProfiler.US is a media source for publicly traded small cap companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.

Call us at (603) 424-4420 or email info@stockprofiler.us

-------------------------------------------

Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.

This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Stock Profiler.US, LLC's News Division includes but is not limited to: http://www.stockprofiler.us, http://www.associatesfortune.com,
http://www.fastmoneytalk.com, http://www.markettelegraph.com,http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.

Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

To view full disclaimers and terms of use, go to http://www.stockprofiler.us/Disclaimer

-------------------------------------------

Keywords: axxe, axxe stock, axxe stock news, axxe stock alerts, axxe company news, axxe small cap stock, small cap news, small cap stock alerts, small cap stock updates, small cap stock news updates, small cap stock profile

StockProfiler.US: Tuesday's Pharmaceutical Company News Updates: Axxess Pharma, Inc. & Cypress Bioscience, Inc.

MARKHAM, ON, Aug 16, 2010 -- Axxess Pharma, Inc. (PINKSHEETS: AXXE), a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription medical products, is pleased to report they have generated $1.3 million in annual sales from their non-constipating multi-vitamin Triferrex 150.

Axxess Pharma, Inc. closed at $0.024 Monday, trading 1,234,168 shares.

Axxess Pharma, Inc. Reports $1.3 Million in Annual Sales From Non-Constipating Multi-Vitamin Triferrex 150

About Axxess Pharma, Inc.

Axxess Pharma, Inc. is a specialty pharmaceutical company that focuses on the marketing of dermatological, therapeutic nutritionals, pain management and diagnostic products in Canada and abroad since 1997. Axxess owns 22 established pharmaceutical prescription products that have proven sales in Canada and internationally. The company has an experienced management team and field sales force to market products nationally to hospitals and retail pharmacies as well as specialized practice areas including Dermatology and Nephrology, Neurology and Urology.

Free AXXE small cap stock news and charts available at http://www.stockprofiler.us/Company/AXXE

For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

SAN DIEGO, CA, August 17, 2010 -- Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that its Board of Directors has sent a letter to Ramius LLC in response to Ramius' letter dated August 11, 2010.

Cypress Bioscience, Inc. closed at $3.81 Monday, trading 206,600 shares.

Cypress Bioscience Sends Letter to Ramius

About Cypress Bioscience

Cypress Bioscience is a pharmaceutical company dedicated to the development of innovative drugs targeting large unmet medical needs for patients suffering from a variety of disorders of the central nervous system. Since 1999, Cypress has received multiple FDA approvals, including Prosorba™, a medical device for rheumatoid arthritis, and Savella® (milnacipran HCl), for fibromyalgia. The Company focuses on generating shareholder value by reaching clinical development milestones as quickly and efficiently as possible. Cypress' currently marketed products include Savella and the Avise PG(SM) and Avise MCV(SM) therapeutic monitoring, diagnostic and prognostic testing services for rheumatoid arthritis. Development-stage assets include CYP-1020 for cognitive impairment in schizophrenia, as well as AVISE-SLE(SM), a lupus diagnostic testing service. More information on Cypress and its products and development assets is available at cypressbio.com/.

For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

StockProfiler.US Announcement!

Membership with access to enhanced stock investing tools is now FREE! Claim yours at http://www.stockprofiler.us/Register

Stay connected with StockProfiler.US – Fan up with us on Facebook (keyword: StockProfiler.US) or follow us on Twitter at http://twitter.com/StockProfilerUS

View free small cap company videos and product reviews at our YouTube channel. Visit http://www.youtube.com/StockProfilerUS

-------------------------------------------

About StockProfiler.US:

StockProfiler.US is a media source for publicly traded small cap companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.

Call us at (603) 424-4420 or email info@stockprofiler.us

-------------------------------------------

Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.

This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Stock Profiler.US, LLC's News Division includes but is not limited to: http://www.stockprofiler.us, http://www.associatesfortune.com,
http://www.fastmoneytalk.com, http://www.markettelegraph.com,http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.

Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

To view full disclaimers and terms of use, go to http://www.stockprofiler.us/Disclaimer

-------------------------------------------

Keywords: axxe, axxe stock, axxe stock news, axxe stock alerts, axxe company news, axxe small cap stock, small cap news, small cap stock alerts, small cap stock updates, small cap stock news updates, small cap stock profile

StockProfiler.US: Small Cap Pharmaceutical Company News: Axxess Pharma, Inc. & A5 Laboratories Inc.

MARKHAM, ON, Aug 16, 2010 -- Axxess Pharma, Inc. (PINKSHEETS: AXXE), a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription medical products, is pleased to report they have generated $1.3 million in annual sales from their non-constipating multi-vitamin Triferrex 150.

Axxess Pharma, Inc. closed at $0.013 Friday, trading 332,829 shares.

Axxess Pharma, Inc. Reports $1.3 Million in Annual Sales From Non-Constipating Multi-Vitamin Triferrex 150

About Axxess Pharma, Inc.

Axxess Pharma, Inc. is a specialty pharmaceutical company that focuses on the marketing of dermatological, therapeutic nutritionals, pain management and diagnostic products in Canada and abroad since 1997. Axxess owns 22 established pharmaceutical prescription products that have proven sales in Canada and internationally. The company has an experienced management team and field sales force to market products nationally to hospitals and retail pharmacies as well as specialized practice areas including Dermatology and Nephrology, Neurology and Urology.

Free AXXE small cap stock news and charts available at http://www.stockprofiler.us/Company/AXXE

For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

MONTREAL, QUEBEC, Aug. 16, 2010 -- A5 Laboratories Inc. (A5 Labs) (OTCBB: AFLB) today announced the appointment of Ms. Valentyna Navala to the position of Director of Microbiology and Interferon Clinical Programs and Mr. Chakib Rhofir to the position of Director of CRO Scientific Affairs.

Laboratories Inc. closed at $0.92 Friday, trading 158,490 shares.

A5 Laboratories Inc. Appoints Senior Managers

About A5 Labs

A5 Labs is a contract research based organization servicing the pharmaceutical and biotechnology companies in North America. The company utilizes its research capabilities to license and acquire novel biotechnology products for development and commercialization.

For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

StockProfiler.US Announcement!

Membership with access to enhanced stock investing tools is now FREE! Claim yours at http://www.stockprofiler.us/Register

Stay connected with StockProfiler.US – Fan up with us on Facebook (keyword: StockProfiler.US) or follow us on Twitter at http://twitter.com/StockProfilerUS

View free small cap company videos and product reviews at our YouTube channel. Visit http://www.youtube.com/StockProfilerUS

-------------------------------------------

About StockProfiler.US:

StockProfiler.US is a media source for publicly traded small cap companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.

Call us at (603) 424-4420 or email info@stockprofiler.us

-------------------------------------------

Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.

This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Stock Profiler.US, LLC's News Division includes but is not limited to: http://www.stockprofiler.us, http://www.associatesfortune.com,
http://www.fastmoneytalk.com, http://www.markettelegraph.com,http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.

Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

To view full disclaimers and terms of use, go to http://www.stockprofiler.us/Disclaimer

-------------------------------------------

Keywords: axxe, axxe stock, axxe stock news, axxe stock alerts, axxe company news, axxe small cap stock, small cap news, small cap stock alerts, small cap stock updates, small cap stock news updates, small cap stock profile

ONTARIO, CA, August 12, 2010 -- Axxess Pharma, Inc. (PINKSHEETS: AXXE), a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription drugs, announces on June 14, 2010 Taylor Capitol, Inc was hired as Investor Relations to replace Mina Mar Marketing Group.

Axxess Pharma, Inc. closed at $0.013 Friday, trading 332,829 shares.

Axxess Pharma, Inc. Provides Update Regarding Mina Mar Marketing Group

About Axxess Pharma, Inc.

Axxess Pharma, Inc. is a specialty pharmaceutical company that focuses on the marketing of dermatological, therapeutic nutritionals, pain management and diagnostic products in Canada and abroad since 1997. Axxess owns 22 established pharmaceutical prescription products that have proven sales in Canada and internationally. The company has an experienced management team and field sales force to market products nationally to hospitals and retail pharmacies as well as specialized practice areas including Dermatology and Nephrology, Neurology and Urology.

Free AXXE small cap stock news and charts available at http://www.stockprofiler.us/Company/AXXE

For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

FOOTHILL RANCH, CA, August 16, 2010 -- Medical Marijuana Inc (PINKSHEETS: MJNA) is pleased to announce progress as they move toward the launch date of August 28.

Medical Marijuana Inc closed at $0.09 Friday, trading 935,068 shares.

Medical Marijuana Inc Agent Base Continues to Expand With 12 Days Until Launch of "The Hemp Network," the World's First Hemp Product Related Network Marketing Company

About Medical Marijuana Inc.

Medical Marijuana Inc recognizes the vast and unequaled opportunities that exist in the rapidly expanding hemp and medical marijuana industries. The scientific recognition of cannabis has brought legalized marijuana use to the forefront of mainstream discussion, thus opening the door for safe and lucrative investment opportunities.

For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

StockProfiler.US Announcement!

Membership with access to enhanced stock investing tools is now FREE! Claim yours at http://www.stockprofiler.us/Register

Stay connected with StockProfiler.US – Fan up with us on Facebook (keyword: StockProfiler.US) or follow us on Twitter at http://twitter.com/StockProfilerUS

View free small cap company videos and product reviews at our YouTube channel. Visit http://www.youtube.com/StockProfilerUS

-------------------------------------------

About StockProfiler.US:

StockProfiler.US is a media source for publicly traded small cap companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.

Call us at (603) 424-4420 or email info@stockprofiler.us

-------------------------------------------

Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.

This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Stock Profiler.US, LLC's News Division includes but is not limited to: http://www.stockprofiler.us, http://www.associatesfortune.com,
http://www.fastmoneytalk.com, http://www.markettelegraph.com,http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.

Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

To view full disclaimers and terms of use, go to http://www.stockprofiler.us/Disclaimer

-------------------------------------------

Keywords: axxe, axxe stock, axxe stock news, axxe stock alerts, axxe company news, axxe small cap stock, small cap news, small cap stock alerts, small cap stock updates, small cap stock news updates, small cap stock profile